Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roselli

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
International Journal of Colorectal Disease|May 15, 2012
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancerPatrizia Ferroni, Silvia Riondino, Ilaria Portarena, et al.
Oncology|July 27, 2007
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancerPatrizia Ferroni, Raffaele Palmirotta, Antonella Spila, et al.
Medical Oncology (Northwood, London, England)|August 24, 2014
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patientsVincenzo Formica, Jessica Luccchetti, David Cunningham, et al.
Biomarkers in Medicine|July 16, 2015
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopeniaFrancesco Cacciatore, David Della-Morte, Claudia Basile, et al.
Rejuvenation Research|May 21, 2011
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemopreventionPatrizia Ferroni, David Della-Morte, Raffaele Palmirotta, et al.
Thrombosis Research|April 9, 2009
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancerRaffaele Palmirotta, Patrizia Ferroni, Annalisa Savonarola, et al.
Cancer Biomarkers : Section a of Disease Markers|July 20, 2016
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatinVincenzo Formica, Cristina Morelli, Patrizia Ferroni, et al.
Pharmacological Research|March 14, 2018
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?Ornella Franzese, Fiorenzo Battaini, Grazia Graziani, et al.
Expert Opinion on Biological Therapy|February 28, 2013
Monoclonal antibodies in gastrointestinal cancersGiuseppe Bronte, Giuseppe Cicero, Stefania Cusenza, et al.
International Journal of Cancer|July 22, 2014
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratioPatrizia Ferroni, Silvia Riondino, Vincenzo Formica, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Colorectal Disease|May 15, 2012
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancerPatrizia Ferroni, Silvia Riondino, Ilaria Portarena, et al.
Oncology|July 27, 2007
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancerPatrizia Ferroni, Raffaele Palmirotta, Antonella Spila, et al.
Medical Oncology (Northwood, London, England)|August 24, 2014
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patientsVincenzo Formica, Jessica Luccchetti, David Cunningham, et al.
Biomarkers in Medicine|July 16, 2015
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopeniaFrancesco Cacciatore, David Della-Morte, Claudia Basile, et al.
Rejuvenation Research|May 21, 2011
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemopreventionPatrizia Ferroni, David Della-Morte, Raffaele Palmirotta, et al.
Thrombosis Research|April 9, 2009
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancerRaffaele Palmirotta, Patrizia Ferroni, Annalisa Savonarola, et al.
Cancer Biomarkers : Section a of Disease Markers|July 20, 2016
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatinVincenzo Formica, Cristina Morelli, Patrizia Ferroni, et al.
Pharmacological Research|March 14, 2018
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?Ornella Franzese, Fiorenzo Battaini, Grazia Graziani, et al.
Expert Opinion on Biological Therapy|February 28, 2013
Monoclonal antibodies in gastrointestinal cancersGiuseppe Bronte, Giuseppe Cicero, Stefania Cusenza, et al.
International Journal of Cancer|July 22, 2014
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratioPatrizia Ferroni, Silvia Riondino, Vincenzo Formica, et al.
Pageof 17